Biocon Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Biocon obtains approval for weight management drug,Liraglutide, in the United States".
Biocon Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Biocon obtains approval for weight management drug,Liraglutide, in the United States".